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OBJECTIVE: Type 1 diabetes mellitus (T1DM) and celiac disease (CD) are autoimmune diseases and have similar genetic patterns.
T1DM treatment is based on diet, physical activity and insulin therapy, whereas CD depends on dietary changes with restriction of
wheat, rye and barley. The aim of the study was to evaluate the quality of life (QoL) of individuals with the association of T1DM and
CD, to characterize their nutritional status and to compare it with those with only one disease and healthier controls.
SUBJECTS/METHODS: Sixty patients controlled by sex, age and body mass index (BMI) were stratified by previous diagnosis in:
T1DM and CD (DMCD group); T1DM (DM group); CD (CD group); or healthy participants (HC). The SF-36 questionnaire was applied
to assess psychological well being and results were compared with glycemic control and presence of complications related to
diabetes, adhesion to gluten-free diet (GFD). Nutritional status and body mass composition were determined by BMI, waist
circumference, bioimpedance, general laboratory tests and whole-body densitometry.
RESULTS: The time of diagnosis of T1DM was similar between DMCD and DM groups; however, the duration of CD was significantly
higher in the CD group compared with DMCD. The SF-36 analysis revealed statistically significant differences between DM and HC
groups in two domains: general health (P= 0.042) and energy/vitality (P= 0.012). QoL was also correlated with compliance to a GFD,
and scores were similar in both groups: DMCD and CD. Forty percent of individuals in the CD group had visceral fat area above
100 cm2, as opposed to 20% in the other groups.
CONCLUSIONS: Individuals of DMCD group had similar scores to DM, CD and HC on QoL, as well as on their nutritional status and
bone metabolism. Thereby, we should conclude that the association of T1DM and CD did not deteriorate their health status.
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INTRODUCTION
Type 1 diabetes mellitus (T1DM) and celiac disease (CD) are
autoimmune diseases caused by the interactions of genetic and
environmental factors. Both diseases have genetic patterns linked
to HLA-DQ2 and HLA-DQ8, resulting in a reported prevalence of
CD in T1DM five to seven times higher than in the general
population.1 T1DM treatment is based on the regular physical
activity, and nutritional and insulin therapy.2 Hence, the medical
prescription of multiple doses of insulin and carbohydrate
counting showed better glycemic control in individuals with
DM1, avoiding the glucose restriction and the negative impact of
dietary restriction.3
Similarly, treatment for CD is based on the dietary therapy, with
restriction of wheat, rye and barley, responsible for the immune
system activation and intestinal damage. Proper gluten restriction
results in a recovery of the CD enteropathy, despite conflicting
results about the adequacy of daily requirements of micronu-
trients and macronutrients. The appropriateness of nutrients is
related to the availability, composition of gluten-free food, cultural
aspects, access to ‘new diets’ and specific nutritional recommen-
dations for each population.4–6 Overall, individuals with adequate
adhesion to the gluten-free diet (GFD) tend to consume smaller
amounts of fibers, iron, calcium, folic acid and vitamin B12.7,8
Some studies have shown an improvement in quality of life
scores (QoL) for those patients with T1DM after initiating
carbohydrate counting and intensive insulin therapy, but the
need for full-time attention to the disease for a long time may
deteriorate their QoL.9,10 Initially, the QoL of celiac patients is
affected by diet restriction; however, it improves ~ 1 year after the
introduction of GFD, even in those with a partial adherence.11,12
Despite the high prevalence of the association between T1DM and
CD, the repercussion of dietary changes imposed by both diseases
on QoL has been poorly evaluated. Therefore, the aim of the study
was to evaluate the QoL of individuals with the association of
T1DM and CD, and to characterize their nutritional status,
nutritional behavior and deficiencies, comparing it with those
with only one disease (T1DM or CD) and healthy controls
PATIENTS AND METHODS
Patients
To evaluate the nutritional status, and characterize usual dietary intake and
impact on QoL of individuals with T1DM associated with CD, without
biases related to sex, age and body mass index (BMI), we used the
parameters of the 15 patients enrolled in the DMCD group to match with
those of participants from the other three groups. Sixty patients controlled
by sex, age and BMI were stratified by previous diagnosis in four groups:
T1DM and CD (DMCD group); T1DM (DM group); CD (CD group); or healthy
participants (HC group). They were recruited from Hospital das Clinicas da
Faculdade de Medicina, Universidade São Paulo, endocrinology and
gastroenterology outpatient clinics, although healthy participants were
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recruited from the nutrition and dietetics division. We adopted as inclusion
criteria: (1) adult individuals aged 18–59 years; (2) type 1 diabetes
diagnosed by presence of antibodies anti-glutamic acid decarboxylase or
anti-islet or C-peptide o0.5 ng ml− 1 or dependence on insulin since
diagnosis of the disease; (3) CD confirmed by antibodies, anti-endomysial
antibodies (anti-EMA) or anti-transglutaminase antibody positives and
typical histologic alterations on intestinal biopsy. The Institutional Review
Board at Hospital das Clinicas approved these studies; all participants
provided signed, informed consent. All patients with diabetes were on
intensive multiple doses insulin therapy, just one patient at DMCD group
was with continuous subcutaneous insulin infusion. The average dose of
insulin was 0.69 ± 0.37 and 0.61 ± 0.19 units per kg per day, group DMCD
and CD, respectively.
Nutritional status and body mass composition
The area of visceral fat was measured using octopolar bioimpedance
(InBody720, Biospace Co. Ltd., South Korea), whereas total body fat
and bone mineral density were assessed by whole-body densitometry
(dual energy X-ray absorptiometry, Hologic Discovery W; Bedford, MA
01730-1401, USA). The registered dietitian nutritionist responsible for the
project execution plan (Joyce Gouveia Nunes-Silva-S) determined nutri-
tional status by BMI and waist circumference, assessed food intake by a 3-
day food record and calculated nutritional composition using the Virtual
Nutri Plus software (Copyright 2012—www.keeple.com.br) and the
Brazilian Food Composition Table, TACO13 and Philippi.14 Results of
macronutrients, fibers and cholesterol were compared with the recom-
mendations of the Brazilian Society of Diabetes,15 and micronutrients to
the references of the Institute of Medicine.16,17
Psychological well-being assessment
We applied the Brazilian version of the SF-36 questionnaire18 and
compared data on QoL among all four groups. The value for each domain
of SF-36 ranges from 0 to 100 (0 being the worst and 100, the best state of
health). For groups with T1DM, SF-36 results were also associated with
glycemic control and presence of complications related to diabetes,
whereas for those with CD, adhesion to diet assessed by Celiac Dietary
Adherence Test (CDAT)19 and anti-EMA were used for comparison. To infer
the degree of commitment to the GFD, we used as criterion for CDAT:
good-diet adhesion, scores o13, low-diet adhesion and scores 417, as
suggested by the authors.19 A single investigator administered both
questionnaires, SF-36 and CDAT during the interview for nutritional
assessment.
Laboratory methods
Anti-EMA were detected by indirect immunofluorescence against human
umbilical cord, adopting o1/10 as cutoff. Glycated hemoglobin (normal
range 4–6%) was determined in whole blood using ion-exchange high-
performance liquid chromatography. General laboratory tests and other
biochemical analyses were carried out using commercial kits, as part of the
routine assessment after overnight fasting.
Statistical analyses
We used Excel 2011 and SPSS version 20.0 (IBM SPSS Statistics for
Windows, IBM Corp., Armonk, NY, USA) for statistical analysis. Variables
were described as mean and s.d., median and range (minimum and
maximum). The analysis of variance test was applied to analyze variance,
whereas normality of data distribution was assumed within each group
using the Kolmogorov–Smirnov test. For variables with statistically
significant differences between groups, we performed the Bonferroni test
for multiple comparisons. We applied the non-parametric test of Fisher and
Pearson correlation coefficient to analyze independent variables, and to
assess the relationship between the variables, respectively. Tests were
performed with a significance level of 5%.
RESULTS
Clinical details are listed in Table 1 and are equal regarding age,
sex and BMI in all groups. The duration of T1DM was similar
between DMCD and DM groups; however, the duration of CD was
significantly higher in the CD group compared to DMCD
(P= 0.0015).
As shown in Figure 1, mean visceral fat area and body fat
percentages were similar among all groups. Yet, 50% of women in
the CD group had visceral fat area above 100 cm2, whereas only
33% of patients achieved this cutoff in the other groups (Table 2).
In general, 64% of women participants were considered as having
increased risk for metabolic complications, according to the
criteria of the World Health Organization.20 On the other hand, all
Table 1. Demographic characteristics of the patients enrolled in the
study according to groups
Groups DMCD DM CD HC P-value
(n= 15) (n= 15) (n=15) (n= 15)
Age (years) 37.4± 13.4 35.5± 12.5 38 ± 11.6 36.8± 12.4 0.955
BMI (kg m− 2) 23.2± 3.0 24.0± 3.1 22.9± 3.6 23.1± 2.7 0.794
Sex (M/F) 3/12 3/12 3/12 3/12
Duration
T1DM (years)
19.8± 9.4 22.2± 9.7 0.493*
Duration CD
(years)
6.4± 3.7 12.2± 9.2 0.0015*
Abbreviations: BMI, body mass index; CD, celiac disease; DM, type 1
diabetes mellitus; DMCD, type 1 diabetes mellitus and celiac disease;
HC, healthy control; M/F, male/female. *P-value: ANOVA or Student's t-test.
Values are means± s.d.
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Figure 1. Visceral fat area and percentage of body fat according to
dual energy X-ray absorptiometry ( DEXA) among all four different
groups. CD, celiac disease only; DM, type 1 diabetes only; DMDC,
type 1 diabetes mellitus and celiac disease; HC, healthy control.
Values are expressed as means ± s.d., median and range (minimum
and maximum). (a) Visceral fat area (cm2) and (b) body fat
percentage.
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male patients had BMI o25 kg m− 2, waist circumference
o94 cm and visceral fat o100 cm2. Taken together, these data
pointed to similarities of clinical characteristics between groups
and the tendency of women with CD to have higher risk of
metabolic complications.
All participants had normocaloric habitual food intake with
nutritional composition appropriately distributed by macronutri-
ents according to standards of the Institute of Medicine16,17 for
the adult population. The quality of diets was adequate for
carbohydrates (except for the DM group) and protein, but
hyperlipidemic (except for HC). The consumption of B12 vitamin
and selenium was satisfactory, whereas fiber, calcium and vitamin
D intake did not reach the daily recommendations in all groups.
Laboratory measurements of vitamins and minerals were similar in
all groups, and within the normal range (Table 3). Nonetheless,
serum levels of folic acid and magnesium were lower in
individuals with CD (DMCD and CD groups) and patients with
diabetes (DMCD and DM groups), respectively (Table 4).
In general, it is possible to conclude that having DM1, CD or
both diseases did not affect the quality of food ingested in
all groups.
We also assessed bone metabolism as shown in Table 3. Our
data show that all laboratorial parameters measured were similar
in all groups, with only three patients with T-score compatible
with osteopenia by densitometry: one patient of DM group and
other two female participants, postmenopausal, aged 48 and 57
years old. One of these belonged to the control group and one to
CD group, reflecting that almost all patients in all groups were
within the normal range for Z-score in the bone mineral density,
without any statistical difference.
Results of psychological well-being assessment estimated by
the SF-36 questionnaire showed a lower score for functional
capacity, physical limitations, pain and social aspects in the
DM and CD groups, but without reaching statistical difference
(Table 5). Two domains of the SF-36 reached statistically significant
differences between DM and healthy control groups: general health
(P=0.042) and energy/vitality (P=0.012). Of particular note was
the negative correlation between glycemic control, assessed by
glycated hemoglobin levels of the DM group, with the domain
energy/vitality (Table 6).
Complications associated with T1DM were not correlated with a
significant difference in health status (P= 0.22), vitality (P= 0.22),
pain (P= 0.27), mental health (P= 0.30), but the domain related to
emotional limitations attained a statistically significant result
(P= 0.00031).
QoL was also correlated with compliance to a GFD assessed by
the CDAT questionnaire and dosage of autoantibodies for those
patients with CD. Scores were similar in both DMCD and CD
groups (P= 0.688). There was good correlation between the
positivity of antibody anti-EMA and poor adherence to the GFD
(P= 0.0381, Fisher's exact test), but without repercussions on QoL.
In short, it is possible to conclude that each disease has its own
impact in QoL, and the association of both diseases did not result
in an important worsening of it.
DISCUSSION
Our data show that nutritional status and BMI analysis were within
the normal range, despite the fact that mean waist circumference
was higher than reference values in 53% of participants in DMCD,
DM and CD groups. In the same way, dual energy X-ray
absorptiometry results did not show significant differences on
visceral fat area or percentage of body fat among the groups
Table 2. Body mass composition of the women patients enrolled in
the study according to groups
Groups DMCD DM CD HC P-value
(n= 12) (n= 12) (n= 12) (n= 12)
BMI (kg m− 1) 23.2± 3.0 24.0± 3.1 22.9± 3.6 23.1± 2.7 0.794
WC 480 cm (n) 8 9 8 6
VF4100 cm2 (n) 4 3 6 4
Abbreviations: BMI, body mass index; CD, celiac disease; DM, type 1
diabetes mellitus; DMCD, type 1 diabetes mellitus and celiac disease; HC,
healthy control; VF, visceral fat area; WC, waist circumference; M/F, male/
female. P-value: analysis of variance. Values are means± s.d.
Table 3. Laboratory measurements of vitamins, minerals, and serum and urinary laboratory biomarkers of bone formation and remodeling and bone
mineral density
Group DMCD DM CD HC P-value
(n= 15) (n=15) (n= 15) (n= 15)
Vitamin B12 (pg ml− 1) 562.9± 298 499.9± 242 414.4± 187 384.2± 147 0.132
Folic acid (ng ml− 1) 9.2± 3.3 15.1± 5.4 8.1± 4.1 12.4± 4.1 o0.001
Iron (μg dl− 1) 72.1± 32.1 73.6± 33.8 86.7± 29.9 95.3± 367 0.184
Copper(μg dl− 1) 96.3± 42.5 81.3± 29.9 82.5± 39.8 78.1± 28.9 0.522
Zinc (μg dl− 1) 57± 18.7 55.1± 17.4 53.3± 13.4 51.7± 6.3 0.821
Magnesium (mg dl− 1) 1.9± 0.2 1.9± 0.2 2± 0.2 2.1± 0.21 0.002
Vitamin D (ng ml− 1) 22.8± 6.8 23.1± 8.2 26.2± 12.9 19.3± 8.2 0.255
Vitamin A (ng ml− 1) 18.2± 11 15.7± 8.6 17.8± 8.3 15.5± 6.2 0.726
S-tCa (mg dl− 1) 9.4± 0.4 9.6± (0,6) 9.3± (0.4) 9.3± (0.4) 0.135
S-iCa (mg dl− 1) 5± 0.2 4.9± 0.3 4.8± 0.2 4.9± 0.2 0.089
Phosphorus (mg dl− 1) 3.5± 0.7 3.5± 0.6 3.3± 0.5 3.5± 0.5 0.605
OH-vit D (ng ml− 1) 22.8± 6.8 23.1± 8.3 26.2± 12.9 19.3± 8.2 0.255
PTH (pg ml− 1) 50.7± 21.6 39.7± 18.3 46.7± 24 46.4± 21.7 0.571
CTX (ng ml− 1) 0.6± 0.5 0.4± 0.2 0.5± 0.3 0.5± 0.3 0.590
P1NP (ng ml− 1) 78.3± 89.1 58.6± 45.6 52.7± 50.3 58.4± 36.7 0.654
U-Ca/24 h (mg vol− 1) 111.8± 103 113.7± 101.4 126.6± 105.6 115.1± 54.5 0.978
24-h UPE (mg vol− 1) 691± 296.9 545.9± 188 511.3± 274.7 432.9± 205.6 0.052
Bone mass (g cm−2) 1.1± 0.1 1.2± 0.13 1.1± 0.13 1.15± 0.1 0.454
Abbreviations: 24-h UPE, 24-hour urine phosphorus excretion; CD, celiac disease; CTX, C-telopeptide of type I collagen; DM, type 1 diabetes mellitus; DMCD,
type 1 diabetes mellitus and celiac disease; HC: healthy control; OH-vit D, OH-vitamin D; P1NP, type I collagen the amino (N)-terminal extension propeptides;
PTH, Parathyroid hormone; S-iCa, serum ionized calcium; S-tCa: serum total calcium; U-Ca/24 h: 24-hour urinary calcium. P-value: analysis of variance. Values
are means± s.d. Statistically significant differences are indicated in bold.
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evaluated, although we clearly observed an increase in visceral
fat area in those in the CD group. Pitoco et al.21 evaluated 120
patients with very similar characteristics to individuals recruited
for this study and observed greater severity of subclinical
atherosclerosis in DMCD subgroup than in individuals with
type 1 diabetes or CD alone. Therefore, they suggested that the
association of these two autoimmune diseases (T1DM and CD)
could accelerate atherosclerosis.
Dietary deficiencies are common at diagnosis and over active
CD, especially of folate and vitamins B12 and B6, due to the loss of
protein and brush border enzymes in the proximal portions of the
intestine, even in the absence of gastrointestinal symptoms.22
Rarely are gluten-free products fortified with folic acid and
vitamins, distinct from what happens with regular food, and this
could be an explanation why approximately one-half of indivi-
duals with CD followed up for 10 years persisted with vitamin
deficiencies, even with adequate gluten restriction.23,24 We found
folic acid deficiency in the celiac patients enrolled in this study
(DMCD and CD groups). They had between 6 and 12 years of
diagnosis with good adhesion to the GFD and steady metabolic
control. In contrast, the detection of lower serum magnesium
concentrations in the DMCD and DM groups appeared to be an
isolated finding. The effect of the association of T1DM and CD on
folic acid deficiency and other hydrosoluble vitamins, as well the
mechanisms responsible for this deficiency, are unknown. None-
theless, the involvement of dietary deficiencies or changes in
absorption and increased urinary excretion in the face of
sustained hyperglycemia may play a role in it.25 However,
published data indicate a potential link between magnesium
deficiency, and cardiovascular risk factors and atherosclerosis,
since magnesium is a natural calcium channel blocker on vascular
smooth muscle and myocardium.26 Thus, a periodic laboratory
evaluation could be advisable to identify individuals, who are
deficient and therefore most likely to benefit from supplementa-
tion of oligoelements and vitamins.
Neither T1DM nor CD by itself or in association influenced
laboratorial parameters of bone metabolism or BMD. This finding
can be explained by the characteristics of the population
evaluated in this study such as: (1) young adults with normal
Table 5. Result of eight domains of health status questionnaire SF-36 by group
Group DMCD DM CD HC P-value
Physical functioning 89± 15 76± 23 73± 28.7 88.7± 9 0.066
Physical role limitations 70± 39.2 61.7± 38.8 65± 39.9 90± 15.8 0.127
Bodily pain 72.5± 28.1 62.1± 27.4 62.1± 27.6 71± 20.2 0.554
General health perceptions 47.5± 15.4 45.3± 19.2 57.4± 19.4 62± 9.3 0.020a
Energy/vitality 55± 19.2 47± 24.3 62.7± 20.8 71.7± 18 0.014a
Social functioning 79.2± 23.5 62.5± 24.5 64.2± 30.2 792± 20 0.117
Emotional role limitations 53.3± 43.3 51.1± 48.6 68.9± 38.8 77.8± 30 0.233
Mental health 61.9± 23.8 54.9± 22.6 68.3± 20.4 74.7±20 0.090
Abbreviations: CD, celiac disease; DM, type 1 diabetes mellitus; DMCD, type 1 diabetes mellitus and celiac disease; HC, healthy control. astatistically significant
differences between DM and HC groups; n= 15 patients per group. P-value: analysis of variance test. The value for each domain of the questionnaire of quality
of life ranges from 0 (the worst state health) to 100 (the best state health). Statistically significant differences are indicated in bold.
Table 4. Results of multiple comparisons by Bonferroni test for
dosage of folic acid and magnesium among all four groups
Groups compared Mean difference s.e. P-value CI (95%)
Lower Upper
Folic acid
DMCD vs DM − 5.96 1.58 0.002 − 10.29 − 1.63
DMCD vs CD 1.13 1.58 40.999 − 3.20 5.46
DMCD vs GC − 3.17 1.58 0.302 − 7.50 1.16
DM vs CD 7.09 1.58 o0.001 2.76 1.42
DM vs GC 2.79 1.58 0.499 − 1.54 7.12
CD vs GC − 4.29 1.58 0.053 − 8.62 0.04
Magnesium
DMCD vs DM 0.02 0.06 40.999 − 0.15 0.19
DMCD vs CD − 0.11 0.06 0.421 − 0.28 0.06
DMCD vs GC − 0.20 0.06 0.010 − 0.37 − 0.04
DM vs CD − 0.14 0.06 0.186 − 0.31 0.03
DM vs GC − 0.23 0.06 0.003 − 0.40 − 0.06
CD vs GC − 0.09 0.06 0.886 − 0.26 0.08
Abbreviations: BMI, body mass index; CD, celiac disease; CI, confidence
interval; DM, type 1 diabetes mellitus; DMCD, type 1 diabetes mellitus and
celiac disease; HC, healthy control. P-value: Bonferroni test. Statistically
significant differences are indicated in bold.
Table 6. Relationship among A1c and domains of health status questionnaire SF-36 in T1DM patients
DMCD DM
Correlation P-value n Correlation P-value n
Physical functioning 0.188 0.501 15 0.412 0.127 15
Physical role limitations 0.049 0.861 15 0.115 0.684 15
Bodily pain -0.054 0.849 15 0.368 0.177 15
General health perceptions 0.091 0.748 15 0.423 0.116 15
Energy/vitality 0.197 0.482 15 0.518 0.048 15
Social functioning 0.216 0.440 15 0.062 0.827 15
Emotional role limitations 0.122 0.666 15 0.063 0.822 15
Mental health 0.239 0.391 15 0.238 0.393 15
Abbreviation: T1DM, type 1 diabetes mellitus. P-value: Pearson product-moment correlation coefficient. Statistically significant differences are indicated in
bold.
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weight; (2) majority of women in reproductive age; (3) similar
intake of calcium and vitamin D; (4) regular glycemic control, thus
without chronic urinary calcium excretion; and (5) celiac patients
with good adhesion to GFD, which somehow contributed to the
formation of adequate bone mass or did not impact it negatively.
The analysis of the SF-36 questionnaire identified that patients
with DM1 achieved lower scores than the control group in general
health and vitality areas, suggesting that ‘having diabetes’ requires
more attention to lifestyle habits and daily treatment, resulting in
an increased perception of the disease. Probably the complexities
involved in managing the treatment influenced the QoL of these
individuals. In addition, the presence of diabetes-related compli-
cations was associated with lower scores on domain role
limitations due to emotional problems. Likewise, in a cohort of
patients with T1DM using multiple doses of insulin, van Dijk et al.10
found a decrease in scores on the assessment by the SF-36
questionnaire and EuroQol-VAS, interpreted as resulting from the
complexity of treatment.
The WESDR (Wisconsin Epidemiologic Study of Diabetic
Retinopathy) evaluated the QoL in individuals with T1DM 10
years after the first phase of the study and concluded that the
development of complications, especially cardiovascular diseases,
as well as changes in employment (retirement, occupying lower
positions and unemployment) were associated with worsening of
QoL.27 Interestingly, we observed the presence of complications
did not affect domains of QoL potentially related to limitations of
the physical functional capacity or pain, but they had a major
impact on the field concerning emotional limitations. Moreover,
we observed a higher prevalence of complications in DM than in
DMCD group, in spite of the similar duration of the disease.
Data published by Bakker et al.3 pointed out a significant
negative impact on QoL related to concerns inherent to diabetes
and social fears of adults with both diseases. Nevertheless, we
observed that individuals with both diseases (DMCD) tended to
achieve higher QoL scores, which means better general health
when compared with DM, CD or control subjects. These results
also diverge from data published by Hallert et al.28 that showed
that CD patients had more difficulty in living with the disease than
those with diabetes or the general population. They referred to a
feeling of ‘being excluded’ from the social context due to the
reduced availability of gluten-free foods. This difference could be
related to either good adherence to both treatments or to the fact
that patients with difficulties in adapting to treatment were more
permissive to food transgressions, omissions in insulin application
and less worried about glycemic control. Therewith, they had
SF-36 scores closer to healthy controls, without the perception of
being sick or influenced by the disease in social life.
The limitation of this study is related to the sample size. The
inclusion of only 15 individuals in each group could have
influenced the lack of statistical significance of waist circumfer-
ence data, the compartmentalized analysis of the total body
weight or even other parameters related to QoL. However, as the
group was matched for the presence of each disease with healthy
controls, the analysis of nutritional health and QoL could be
considered representative for young adults, since there is a low
prevalence of the association of both diseases in the general
population. Likewise, other studies have been published with
small sample size and the authors also reported the difficulty in
recruiting patients with T1DM and CD.29–33
Recently a multicenter randomized controlled trial (CD-DIET)34
has been designed to clarify the impact of a GFD on clinically
relevant outcomes as metabolic control, bone health, glycemic
variability and QoL in children and adults with type 1 diabetes and
asymptomatic CD, making clear the need for specific studies
directed to this population. In this sense, the importance of this
study was to point out that T1DM associated with CD was not
related to worsening QoL, nor did it have a negative impact on
glycemic control in a population of individuals matched for age
and gender with others, who have just one of these diseases and
share similar social environment. This information seems to be
valuable to understand the health-disease process and to
contribute to the re-evaluation of promotion, prevention, treat-
ment and rehabilitation of the patient’s health.
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